Letter | Published:

Klotho converts canonical FGF receptor into a specific receptor for FGF23

Nature volume 444, pages 770774 (07 December 2006) | Download Citation

Subjects

Abstract

FGF23 is a unique member of the fibroblast growth factor (FGF) family because it acts as a hormone that derives from bone and regulates kidney functions, whereas most other family members are thought to regulate various cell functions at a local level1,2,3,4,5. The renotropic activity of circulating FGF23 indicates the possible presence of an FGF23-specific receptor in the kidney6. Here we show that a previously undescribed receptor conversion by Klotho, a senescence-related molecule7, generates the FGF23 receptor. Using a renal homogenate, we found that Klotho binds to FGF23. Forced expression of Klotho enabled the high-affinity binding of FGF23 to the cell surface and restored the ability of a renal cell line to respond to FGF23 treatment. Moreover, FGF23 incompetence was induced by injecting wild-type mice with an anti-Klotho monoclonal antibody. Thus, Klotho is essential for endogenous FGF23 function. Because Klotho alone seemed to be incapable of intracellular signalling, we searched for other components of the FGF23 receptor and found FGFR1(IIIc), which was directly converted by Klotho into the FGF23 receptor. Thus, the concerted action of Klotho and FGFR1(IIIc) reconstitutes the FGF23 receptor. These findings provide insights into the diversity and specificity of interactions between FGF and FGF receptors.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    The ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nature Genet. 26, 345–348 (2000)

  2. 2.

    et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl Acad. Sci. USA 98, 6500–6505 (2001)

  3. 3.

    & Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563–569 (2004)

  4. 4.

    et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J. Clin. Endocrinol. Metab. 87, 4957–4960 (2002)

  5. 5.

    et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N. Engl. J. Med. 348, 1656–1663 (2003)

  6. 6.

    et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429–435 (2004)

  7. 7.

    et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997)

  8. 8.

    et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest. 112, 683–692 (2003)

  9. 9.

    , , & Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol. Rev. 80, 1373–1409 (2000)

  10. 10.

    Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form. Int. J. Mol. Med. 7, 201–209 (2001)

  11. 11.

    & Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50, 191–224 (1995)

  12. 12.

    , & Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor. Blood 96, 1772–1781 (2000)

  13. 13.

    Klotho: a fundamental regulator of aging. Ageing Res. Rev. 1, 627–638 (2002)

  14. 14.

    et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 565, 143–147 (2004)

  15. 15.

    et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146, 4647–4656 (2005)

  16. 16.

    , , , & Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 28265–28270 (2002)

  17. 17.

    , & A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with ‘zinc finger’ sequences. Proc. Natl Acad. Sci. USA 85, 7857–7861 (1988)

  18. 18.

    et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561–568 (2004)

  19. 19.

    et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol. 23, 421–432 (2004)

  20. 20.

    , & Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1α-hydroxylase gene. Endocrinology 143, 683–689 (2002)

  21. 21.

    , , , & Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17, 2393–2403 (2003)

  22. 22.

    , , , & Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 64, 2272–2279 (2003)

  23. 23.

    et al. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J. Biol. Chem. 269, 18320–18326 (1994)

  24. 24.

    & Fibroblast growth factors. Genome Biol. 2, 3005.1–3005.12 (2001)

  25. 25.

    et al. Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein. Mech. Dev. 98, 115–119 (2000)

  26. 26.

    , , & Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. Biochim. Biophys. Acta 1576, 341–345 (2002)

  27. 27.

    et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581–1591 (2003)

  28. 28.

    et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627–1635 (2005)

  29. 29.

    et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J. Clin. Invest. 115, 2202–2208 (2005)

  30. 30.

    et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.. Endocrinology 143, 3179–3182 (2002)

Download references

Acknowledgements

We thank R. Imai, J. Murakami, M. Sato-Fujisawa, R. Hino, K. Sakuma, K. Ono and N. Yoshii for technical assistance, and Y. Nabeshima, T. Yoneya, T. Muto, T. Kawata, Y. Aono, J. Yasutake, N. Kasai and other members of our laboratories for advice and discussion. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, and from the Ministry of Health, Labour, and Welfare, Japan.

Author information

Affiliations

  1. Pharmaceutical Research Laboratories, Kirin Brewery Co., Ltd, 3 Miyahara, Takasaki, Gunma 370-1295, Japan

    • Itaru Urakawa
    • , Yuji Yamazaki
    • , Takashi Shimada
    • , Kousuke Iijima
    • , Hisashi Hasegawa
    • , Katsuya Okawa
    •  & Takeyoshi Yamashita
  2. Division of Nephrology and Endocrinology, Department of Internal Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

    • Toshiro Fujita
    •  & Seiji Fukumoto

Authors

  1. Search for Itaru Urakawa in:

  2. Search for Yuji Yamazaki in:

  3. Search for Takashi Shimada in:

  4. Search for Kousuke Iijima in:

  5. Search for Hisashi Hasegawa in:

  6. Search for Katsuya Okawa in:

  7. Search for Toshiro Fujita in:

  8. Search for Seiji Fukumoto in:

  9. Search for Takeyoshi Yamashita in:

Competing interests

Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Corresponding author

Correspondence to Itaru Urakawa.

Supplementary information

PDF files

  1. 1.

    Supplementary Figure 1

    Schematic illustration of the proposed FGF23-specific receptor that is composed of Klotho and FGFR1(IIIc).

  2. 2.

    Supplementary Figure 2

    The specific binding of FGF23 generated by Klotho.

  3. 3.

    Supplementary Figure 3

    Egr-1 protein was induced by FGF23 in Klotho-expressing Peak rapid cells.

  4. 4.

    Supplementary Figure 4

    Klotho-dependent Egr-1 reporter activation by diluted serum samples from Klotho deficient mice.

  5. 5.

    Supplementary Figure 5

    The FGFR1(IIIc)-Fc fusion protein specifically decreases FGF23 induced luciferase activity of the Egr-1 reporter.

  6. 6.

    Supplementary Figure 6

    Effects of GAGs on the FGF23 action.

Word documents

  1. 1.

    Supplementary Discussion

    This file contains an additional discussion of the findings of this paper.

  2. 2.

    Supplementary Tables

    This file contains Supplementary Tables 1–4.

  3. 3.

    Supplementary Methods

    This file contains additional details on the methods used in this study.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature05315

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.